ConvaTec Group PLC (LON:CTEC)
London flag London · Delayed Price · Currency is GBP · Price in GBp
255.00
-3.40 (-1.32%)
Mar 31, 2025, 1:44 PM BST

ConvaTec Group Company Description

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma.

In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes.

Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson’s disease.

The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers.

It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

ConvaTec Group PLC
ConvaTec Group logo
Country United Kingdom
Founded 1978
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 10,489
CEO Karim Bitar

Contact Details

Address:
20 Eastbourne Terrace
London, W2 6LG
United Kingdom
Phone 44 11 8952 8100
Website convatecgroup.com

Stock Details

Ticker Symbol CTEC
Exchange London Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number GB00BD3VFW73
SIC Code 3842

Key Executives

Name Position
Karim Bitar Chief Executive Officer and Director
Jonathan Peter Mason Group Chief Financial Officer and Director
John Haller Executive Vice President and Chief Quality and Operations Officer
Dr. Divakar Ramakrishnan Ph.D. Executive Vice President, Chief Technology Officer and Head of Research and Development
James Edward Spencer Kerton EVice President, General Counsel and Company Secretary
Emma Rose Executive Vice President and Chief People Officer
Kjersti Grimsrud Biotechnology, M.Sc. President and Chief Operating Officer of Infusion Care
David Shepherd President and Chief Operating Officer of Global Advanced Wound Care
Seth R. Segel President and Chief Operating Officer of Continence Care and Home Services Group
Evelyn Douglas J.D. Executive Vice President and Chief Strategy and Business Development Officer